Delcath Systems Reports Fourth Quarter and Full Year 2022 Re

NEW YORK, March 27, 2023 /PRNewswire/ -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today reported business... | March 27, 2023

Related Keywords

United States , Germany , German , Ben Shamsian , Johnr Sylvester , Gerard Michel , Serrado Capital , International Toll , Drug Administration , Nasdaq , Prnewswire Delcath Systems Inc , Stonepine Capital Management , Delcath Systems Inc , Company Venture Opportunity Fund , Single Center Study , Delcath Systems , Hepatic Delivery System , Prescription Drug User Fee Act , Vivo Capital , Logos Capital , Rosalind Advisors , Hepatocellular Carcinoma , Chief Executive Officer , Sheet Highlights , Monday March , Toll Free , Access Code , United States Food , Delivery System , Private Securities Litigation Reform Act , Seriesf Preferred Stock , Relations Contact , Stockholder Equity , Consolidated Statements , Nc Stock Exchange , News , Information , Press Release , Few , Arch , 023 , Delcath , N , Interventional , Ncology , Company , Ocused , The , Treatment , F , Primary , End , Metastatic , Cancers , Oday , Eported Dcth Us24661p8077 ,